Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Masi, G
3866  Ergebnisse:
Personensuche X
?
1

RFX-mod2 diagnostic capability enhancements for the explora..:

Carraro, L. ; Zuin, M. ; Abate, D....
Nuclear Fusion.  64 (2024)  7 - p. 076032 , 2024
Link: https://doi.org/10.1088/..
 
?
2

381P Evaluation of the prognostic impact of circulating fre..:

Grelli, G. ; Crucitta, S. ; Genovesi, V....
Annals of Oncology.  35 (2024)  - p. S154 , 2024
Link: https://doi.org/10.1016/..
 
?
3

167P Non-viral aetiology subgroup of the phase III HIMALAYA..:

Monzon, M.E. Reig ; Tam, V.C. ; Sangro, B....
Annals of Oncology.  35 (2024)  - p. S75-S76 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S79 , 2024
Link: https://doi.org/10.1016/..
 
?
5

300P Prognostic and predictive role of FGFR2 and IDH1 targe..:

Genovesi, V. ; Rimini, M. ; Pressiani, T....
Annals of Oncology.  35 (2024)  - p. S127 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Identification of factors associated with primary refractor..:

Manfredi, G.F. ; Fulgenzi, C.A.M. ; D'Alessio, A....
Digestive and Liver Disease.  56 (2024)  - p. S8-S9 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C. AM...
Digestive and Liver Disease.  56 (2024)  - p. S76-S78 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S87 , 2024
Link: https://doi.org/10.1016/..
 
?
9

53P Trifluridine/tipiracil plus capecitabine and bevacizuma..:

Ciracì, P. ; Conca, V. ; Moretto, R....
Annals of Oncology.  35 (2024)  - p. S25-S26 , 2024
Link: https://doi.org/10.1016/..
 
?
10

185P The combined role of patients (pts) gender and disease..:

Cesario, S. ; Genovesi, V. ; Rimini, M....
Annals of Oncology.  35 (2024)  - p. S83 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Predicting early recurrence after resection of initially un..:

Moretto, R. ; Germani, M.M. ; Borelli, B....
ESMO Open.  9 (2024)  4 - p. 102991 , 2024
Link: https://doi.org/10.1016/..
 
?
12

162TiP Phase II study of consolidation treatment with holmi..:

Borelli, B. ; Bargellini, I. ; Carullo, M....
Annals of Oncology.  35 (2024)  - p. S72-S73 , 2024
Link: https://doi.org/10.1016/..
 
?
13

63P FOLFOXIRI/bevacizumab (bev) versus doublets/bev as init..:

Marmorino, F. ; Antoniotti, C. ; Meinert, F.M....
Annals of Oncology.  35 (2024)  - p. S30 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S92-S93 , 2024
Link: https://doi.org/10.1016/..
 
?
15

An overview of the evolution of the modeling of reflectomet..:

da Silva, F. ; Heuraux, S. ; Ribeiro, T....
Fusion Engineering and Design.  202 (2024)  - p. 114354 , 2024
Link: https://doi.org/10.1016/..
 
1-15